ArticleScientific reports2025
Explainable illicit drug abuse prediction using hematological differences.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Differentiating Alcohol and Substance Use Disorders Using Multiclass Machine Learning Models Based on Routine Hemogram Parameters.Healthcare (Basel, Switzerland) · 2026Article
- Computational Approach to Select Lead-Like Compounds From an Opioid Class of Novel Psychoactive Substances.Chemistry & biodiversity · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aimed to develop a reliable and explainable predictive model for illicit drug use (IDU). The model uses a machine learning (ML) algorithm to predict IDU using hematological differences between illicit drug users (IDUr) and non-users (n-IDUr). A total of 286 IDUr and 302 n-IDUr were included in this study. By comparing the IDU prediction performance of eight ML models, an explainable LGB model with 13 features was established, which could accurately predict IDU in both internal (area under the curve [AUC] = 0.925) and external (AUC = 0.915) validation sets. Using SHapley Additive exPlanations (SHAP) to explain our prediction model, we found that chloride (Cl), β-hydroxybutyrate (BHB), and anion gap (AG) had a strong influence on the results predicted. Many of the features used for model training are interrelated, serving as important indicators of kidney, liver, and thyroid function in hematological examinations. Combining these manifestations can enable doctors to perform preliminary screening for IDU while conducting corresponding organ examinations in ordinary patients, which has a profound importance in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.